Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2
Clinical trial NCT01763827 · COMPLETED
Trial details
- NCT number
- NCT01763827
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-21
- Primary completion
- 2013-10-10
- Enrollment
- 615
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.